Accreditation Information October 2024

OVERVIEW

This conference provides Physicians and Healthcare Providers evidence-based research and clinical protocols on new procedures, methods, and topics in Age Management Medicine that will increase competency, knowledge and provide treatment tools that improve patient outcomes and patient satisfaction.

OBJECTIVES

• Compare and Contrast the areas that Functional medicine and Age Management medicine are similar and have similar evidence-based patient treatment protocols.
• Recognize treatment options for gut health, chronic inflammation, hormone in-balance and sleep disorders.
• Recognize the science and current case studies behind the use of Estradiol, Progesterone and Testosterone for women
• Recognize hormone testing methodologies and hormone delivery systems and how to apply those in a clinical setting to improve patient outcomes.
• Discover how Botulinum toxin and PRP can be used as a treatment for sexual dysfunction in both men and women.
• Describe new evidence based treatment interventions for cognitive decline.
• Describe Biomarkers which are practical and important to Age Management clinicians.
• Identify which Bio-markers are appropriate and how they will be clinically useful to evaluate and monitor patients.
• Recognize which types of AI can currently be used in healthcare and how they can benefit patients and patient outcomes.
• Recognize that AI can be used to assess the degree of inflammation and evaluation risk of CVD
• Recognize that generally health is frequently based on the “Gut”
• Explore the causes of gut health disorders, testing options and treatment options.
• Recognize the need for testosterone supplementation in men to prevent disease or death.
• Identify evidence based clinical protocols developed using Plasma Exchange and the equipment and methods required to enhance an impaired immune system for superior patient outcomes
• Identify the science behind the use of HBOT, what health issues can be addressed and how to implement using HBOT therapies.
• Identify the science behind Vagus Nerve Stimulation, and what health aspects can benefit.
• Recognize how to stimulate the nerve and use this as a clinical treatment when appropriate
• Compare and contrast pharmaceutical, nutraceutical use of GLP-1 in Female Patients.
• Review supplements with mTOR-inhibiting and Autophagy activating properties and combination therapies.
• Identify strategies to promote health aging.
• Identify proper clinical procedures in Bioenergetic Medicine for proper assessment and development of a patient treatment plan

ACCREDITATION:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Academy and the Age Management Medicine Group (AMMG). Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:

Medical Academy designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:

All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

• AMMG PLANNING COMMITTEE
• Florence Comite, M.D
• Elliot Dinetz, M.D., ABFM, ABAARM
• Mark Gordon, M.D.
• Rob Kominiarek, D.O. FACOFP
• Edwin Lee, M.D.
• Luis Martinez, M.D.
• Cesar M. Pellerano, M.D.
• John J. Rush, M.D., FACEP, MBA, MHA
• George Shapiro, M.D.

COURSE DIRECTOR

Gregory R. Fillmore, Director of Education, AMMG

SUMMARY OF DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

None of the following faculty, planners and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies who’s primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patient.

Speakers
William Clearfield, D.O.
Florence Comite, M.D
Derrick DeSilva, Jr., M.D.
Elliot Dinetz, M.D., ABFM, ABAARM
Joseph Dituri, Ph.D.
Greg Eckel, N.D., LAc.
Jeffrey Graham, M.D., MPH
Mark Gordon, M.D.
Edwin Lee, M.D.
Cesar Pellerano, M.D.
Kathryn Retzler, N.D.
Frank Shallenberger, MN.D., HMD
George Shapiro, M.D.
Jin-Xiong She, Ph.D.
Kimberly Suriano, M.D.
Dushyant Viswanathan, M.D.
Edward Walker, Ph.D.
Jason White, MS, CSCS

The following speakers, planners and reviewers have indicated relevant financial relationships with the following commercial interests:

• Syed Asad, M.D. declares the following interests: he is a Faculty/Instructor for Otzuka, a Speaker & Advisor for Abbvie
• Charles Runels, M.D., FACOG declares the following interests: Researcher and Owner, Cellular Medicine Association
• Alexandra Runnels, M.D., FACOG declares the following interests: Teaching Role, Cellular medicine Association
• Mark Tager, M.D. declares the following interests: Speaker for Designs for Health, Electrocore and Calocurb and Scientific Board Member, Enzymedica,
• Paul Thompson, M.D. declares the following interests: Advisory Board /Stock Holder Zeo Scientix, Stock Holder Launch Medical

All of the relevant financial relationships listed above have been mitigated by the Medical Academy and the Age Management Medicine Group (AMMG).

Educational Support:

AMMG received no educational support in the form of Grants for this educational course.